Congo, Democratic Republic of the vs South Africa: Access to anti-retroviral drugs, male
Congo, Democratic Republic of the
75.0%
in 2024
South Africa
75.0%
in 2024
Congo, Democratic Republic of the rank
55th
South Africa rank
55th
Access to anti-retroviral drugs, male over time
- Congo, Democratic Republic of the
- South Africa
How they compare
Congo, Democratic Republic of the currently reports 75.0% against 75.0% in South Africa, a difference of 0.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was South Africa ahead.
Congo, Democratic Republic of the ranks 55th and South Africa ranks 55th of 141 countries.
South Africa has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Congo, Democratic Republic of the | South Africa | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.9% | 4.4% | 2.5% | South Africa |
| 2010s | 19.5% | 45.1% | 25.6% | South Africa |
| 2020s | 68.0% | 71.6% | 3.6% | South Africa |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Congo, Democratic Republic of the or South Africa?
- Congo, Democratic Republic of the, at 75.0% against 75.0% in South Africa as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Congo, Democratic Republic of the and South Africa?
- 0.0%, with Congo, Democratic Republic of the ahead.
- How many years of comparable data are there for Congo, Democratic Republic of the and South Africa?
- 25 years are reported by both, from 2000 to 2024.
- How do Congo, Democratic Republic of the and South Africa rank globally for access to anti-retroviral drugs, male?
- Congo, Democratic Republic of the ranks 55th and South Africa ranks 55th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.